樂觀
$494.79
情境價格
$436.950
-7.079 (-1.62%)收盤時
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.
BofA
$465
2026-10-09
BofA
2026-10-09
目標價
$465
Barclays
$500
2026-10-07
Barclays
2026-10-07
目標價
$500
Guggenheim
$490
2026-10-01
Guggenheim
2026-10-01
目標價
$490
Goldman Sachs
$515
2026-09-21
Goldman Sachs
2026-09-21
目標價
$515
UBS
$490
2026-09-09
UBS
2026-09-09
目標價
$490
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Waters Launches AI Link Software to Drive Laboratory Automation

Market Outlook: Tech Stock Dynamics and Investment Opportunities

Waters Launches BD FACSDiscover A7 Cell Analyzer for Enhanced Flow Cytometry

Waters CEO to Participate in J.P. Morgan Conference

Waters CEO to Participate in J.P. Morgan Conference
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).
Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.
15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。